Replimune Group IncHere is the public summary page for Replimune Group Inc. Please login to see the complete information for Replimune Group Inc including detailed analysis of price, sentiment, fundamentals, flow, forecast models, alerts and much more. Also you can see how Replimune Group Inc stacks up relative to its peers. |
| Darwin Score | -17 |
| Ticker | REPL |
| Latest Price | 5.09 USD as of close on 13-Aug-2025 |
| 3 Month price range | 2.81 to 12.63 USD |
| Market Capitalisation | 409.79Mn USD |
| Country | United States of America |
| Region | North America |
| Economic Sector | Health Care |
| Business Sector | Pharmaceuticals, Biotechnology & Life Sciences |
| Industry | Biotechnology |
| Sub-Industry | Biotechnology |
| Description | Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development and commercialization of oncolytic immunotherapies to treat cancer. The company's proprietary oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF for a range of solid tumors. The company is also developing RP2 that express an anti-CTLA-4 antibody-like protein to block the inhibition of the immune response otherwise caused by CTLA-4; and RP3, which express immune-activating proteins that stimulate T cells. Replimune Group, Inc. was founded in 2015 and is headquartered in Woburn, Massachusetts. See More ... |
| Company URL | https://www.replimune.com |
| See Darwins Full Analysis for Replimune Group Inc |
Tell Me About
Tell Me About (TMA) is Darwins structured scoring system for assets. Here are the scores from the key TMA sections for Replimune Group Inc. Further information and full detail is available when you login.
| TMA Part | Focus of Analysis | TMA Score |
|---|---|---|
| Price | Analysis of performance, trend, RSI, OBV and moving averages | -12 |
| Sentiment | News and Candle Patterns. | -1 |
| Fundamentals | Analyst Ratings, Valuation and Dividend analysis. | +2 |
| Flow | Institutional, Fund and Insider buying and selling. | -8 |
| Models | Forecast models. | +2 |
Alerts
There are 1 live alerts for Replimune Group Inc. All the alerts are positive.
- Oversold - The 5 month RSI is +25.7. (Positive)
Peer Comparison
There are 27 peers of Replimune Group Inc.
Share 
